Team:GeorgiaTech

From 2013.igem.org

(Difference between revisions)
Line 132: Line 132:
     </body>
     </body>
</html>
</html>
-
==Objective==
 
-
===planned results and significance of work===
 
-
 
-
The objective for our project is ultimately to express human integrins on the surface of E.Coli cells.  By expressing
 
-
 
-
human integrins on bacteria cells, we can manipulate the cells to respond to specific stimuli in their environment. The
 
-
 
-
specific integrin we are trying to express on the E.Coli cell has the ability to bind to fibrinogen. If it is successfully placed
 
-
 
-
on the cell, the cell will be able to bind to fibrinogen, effectively coagulating or clotting blood. This has applications in the
 
-
 
-
medical field, where the integrin-containing E.Coli (BioBots, as we like to call them) can be administered as a topical solution
 
-
 
-
and prevent excessive bleeding on major surface wounds.  A bacteria’s ability to express integrins has other applications as
 
-
 
-
well. Since the bacteria will be able to send and receive signals to its environment, the bacteria can theoretically detect and
 
-
 
-
locate cancer cells, as well as any other specific cell or structure of concern. These novel bacterial robots will represent the
 
-
 
-
first prokaryotic use of heterodimeric integrins for a sensory function and will represent a platform that will enable future
 
-
 
-
“design” of integrins sensory function through molecular evolution techniques.
 

Revision as of 21:47, 27 September 2013

Georgia Tech iGEM